Controlled human infection models in vaccine development: what’s new in 2025?
M B. Laurens, A P. Durbin, M Cavaleri et al.
To 1000L and beyond: streamlining AAV manufacturing with transfection complex stabilization
Leisha Kopp, Mason Bonitz
Leveraging fluid dynamics characterization to accelerate cell therapy product development
Hamza Patel, Tom Heathman
AAV production and purification: key steps from design to GMP readiness
G Ganjam, F Leseigneur, E Jackson-Holmes